Ticagrelor metabolite M5 是 Ticagrelor 的代谢物，是 P2Y12 受体的第一个可逆口服拮抗剂。与氯吡格雷相比，替格瑞洛对 ADP 受体具有更快和更一致的抑制作用。替格瑞洛用于治疗急性冠状动脉综合征（ACS）。
产品描述
Ticagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster and more consistent inhibition on ADP-receptors. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
Cas No.
1251765-07-7
分子式
C14H22N6O4S
分子量
370.43
别名
AR-C133913XX;Ticagrelor metabolite M5,;T437700;替格瑞洛杂质H
储存和溶解度
DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
